Please login to the form below

Not currently logged in


This page shows the latest CALD news and features for those working in and with pharma, biotech and healthcare.

bluebird bio reveals plans to launch two gene therapies

bluebird bio reveals plans to launch two gene therapies

Eli-cel is under priority review for the treatment of early active cerebral adrenoleukodystrophy (CALD) in patients under the age of 18 who do not have an available and willing matched ... CALD is a rare neurodegenerative disease that primarily affects

Latest news

More from news
Approximately 6 fully matching, plus 3 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Subscribe to our email news alerts

Featured jobs


Add my company
Porterhouse Medical Group

The Porterhouse Medical Group provides powerful, insight-driven, healthcare communication services to the pharmaceutical industry across the globe, with a focus...

Latest intelligence

William Kilgallon
How the Royal Society’s EiR programme can help to drive UK innovation
Box 1
Strategic commitment
KOL Ambassador Program & Podcast Creation: A Customer Story